CVRS stock: buy or sell?

CVRS stock price: $4.26 -0.23% At close on August 19th, 2019

Updated on:
August 19th, 2019


After climbing for 4 sessions, Monday Corindus Vascular Robotics stayed stable a lame -0.23%, closing at $4.26. On Aug/8 CVRS rocketed a super good 43.46%.

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures.

Should I buy CVRS stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Corindus Vascular Robotics stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Corindus Vascular Robotics stock a buy?

Financial institutions and banks publish stock ratings everyday. Unfortunately, we couldn't detect any rating for CVRS stock for the last 30 days.

CVRS stock analysis

Daily outlook

After climbing for 4 sessions, Monday Corindus Vascular Robotics stayed stable a lame -0.23%, closing at $4.26.

After climbing for 4 days, Monday Corindus Vascular Robotics stayed steady a lame -0.23%, closing at $4.26. Price climbed above $2.91 breaking the short term down trend. $2.91 should act now as a support and could be tested in the coming days. On Aug/8 CVRS price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.

CVRS stock chart (daily)

Weekly outlook

Corindus Vascular Robotics shares remained steady -0.23% this week, ending at $4.26. Early August CVRS rocketed an astounding 44.16% in just one week. Late July CVRS plummed a hair-raising -14.64% in just one week.

Corindus Vascular Robotics stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Early January CVRS price bounced up over the SMA of 40 weeks that acted as support stopping new slides. Since late October 2018 when SMA20w and SMA40w crossed up, CVRS price gained $3.18 per share (294.44%).

CVRS stock chart (weekly)

CVRS stock price history

CVRS IPO was on August 18th, 2014 at $3.15 per share1. Since then, CVRS stock grew a 35.20%, with a yearly average of 7.00%. If you had invested $1,000 in CVRS stock in 2014, it would worth $352.00 today.

1: Adjusted price after possible price splits or reverse-splits.

CVRS stock historical price chart

CVRS stock reached 52-week highs on Aug/9 at $4.30, and all-time highs 2015-06-15 with a price of 4.58.

CVRS stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not detected any price target for Corindus Vascular Robotics stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After posting its last earnings report on November, Corindus Vascular Robotics . As soon as we get its posted EPS from the earnings report, we will extend this report.
CVRS earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual sales report draw an impressive increase of 11.72% to $10.78 M dollars. When comparing 2018 vs 2017, similarly, profit margin (that is, the net income divided by revenues) skyrocketed a 29.06% to -324.54%.

To have an updated picture of the financial situation of Corindus Vascular Robotics, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q3 that can be compared to 2018 fiscal year results. Annual Corindus Vascular Robotics TTM sales up to September 2018 were $10.30 and earnings were $-35.53 M USD. If we compare this TTM figures with the last reported annuality, we can review Corindus Vascular Robotics business evolution since December 2018: Annual turnover up to September, compared to lastest yearly report, declined an awful -4.48%. Regarding profit margin, Corindus Vascular Robotics plummed -20.43% to -324.54%

CVRS annual Sales and Income evolution
2013$0.90 M-$-14.69 M-1639.5%-
2014$36 M3,917.86%$0.00 M0.0%-100.00%
2014$2.98 M-91.71%$-24.54 M-822.7%0.00%
2015$2.73 M-8.51%$-28.76 M-1054.0%17.20%
2016$2.84 M4.14%$-33.08 M-1163.9%15.00%
2017$9.65 M239.55%$-34.12 M-353.6%3.16%
2018$11 M11.72%$-34.99 M-324.5%2.54%
TTM $10 M-4.48%$-35.53 M-345.0%1.53%

Quarterly financial results

Corindus Vascular Robotics posted $2.96 M in sales for 2018-Q3, a 77.66% up compared to previous quarter. Reported quarter earnings marked $-7.60 million with a profit margin of -256.76%. Profit margin climbed a 338.37% compared to previous quarter when profit margin was -595.14%. When comparing sales to same quarter last year, Corindus Vascular Robotics sales marked an astounding increase and boosted a 21.98%. Looking back to recent quarterly results, Corindus Vascular Robotics posted 2 negative quarters in a row.
CVRS quarterly Sales and Income evolution
2017-Q1$1 M-$-9.89 M-1272.8%-
2017-Q2$2 M190.86%$-8.41 M-372.1%-14.96%
2017-Q3$2 M7.30%$-7.85 M-323.8%-6.62%
2017-Q4$4 M72.78%$-7.97 M-190.2%1.50%
2018-Q1$1 M-64.56%$-10.05 M-676.8%26.08%
2018-Q2$2 M12.12%$-9.91 M-595.1%-1.40%
2018-Q3$3 M77.66%$-7.60 M-256.8%-23.35%
2018-Q4$5 M57.98%$-7.44 M-159.1%-2.11%

Corindus Vascular Robotics ownership

When you are planning to invest in shares of a stock, it's worth to check its ownership structure.

Corindus Vascular Robotics shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 23.78% of all shares.

In case of Corindus Vascular Robotics stock, 45.96% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for CVRS stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related stocks:

Market cap$815.0 M$59.4 B
Total shares191.3 M1,390.0 M
Float shares132.6 M1,390.0 M
  - Institutional holdings (%)46.0%93.4%
  - Insider holdings (%)23.8%0.2%
Shares in short selling0.0%0.0%

CVRS summary

Monday, August 19th, 2019
Day range$4.25 - $4.27
Previous close$4.27
Session gain-0.23%
Average true range$0.25
50d mov avg$3.06
100d mov avg$2.70
200d mov avg$1.99
Daily patternlb06c
Weekly pattern lt06a

Corindus Vascular Robotics performance

To measure stock performance is always good to compare with competitors or related stocks. We selected Array as the bechmarking frame for Corindus Vascular Robotics stock.
CVRSCorindus Vascular...60.75%189.80%313.59%
BSXBoston Scientific11.07%5.45%23.07%

Corindus Vascular Robotics competitors

Choosing a list of competitors for Corindus Vascular Robotics it's tough. We selected just one public company that in our opinion is related to and can be considered Corindus Vascular Robotics competitor: